Thus, we can only use the TCGA-COAD to explore the association between the IL1-MT and prognosis of COAD patients treated with ICIs based on multi-omics analysis; third, in future research, molecular and animal experiments are needed to further verify our results. This evidence concerns the gene IL1B and colon adenocarcinoma.